Clinical Commissioning Policies
This page lists the Clinical Commissioning Policies – known locally as Lavender Statements – that have been adopted by OCCG’s Board. NHS organisations caring for Oxfordshire patients must take account of these statements when considering treatment or referral to other specialists.
088e Optimising Self Care by Appropriate use of Over the Counter Medicines (Restricted Prescribing List)
101e Surgical Management of Otitis Media
102e Tonsillectomy
112e Dilatation And Curettage Policy Recommendation
113e TVPC58 Hysterectomy v2.0
114b P1NP Testing in Osteoporosis
115c Implementation of NICE IPG, MTG and DTG
119b Chronic Fatigue Syndrome
120c Primary Restless Legs Syndrome (RLS) (Willis-Ekborn Disease)
126c Cataract Removal in Adults
133b Cannabinoids In The Management Of Multiple Scelerosis And Chronic Pain
137d Ganglion Cysts
143b Funding of NICE TAGs
153c Excess Treatment Costs
160b Methylphenidate and Atomoxetine for ADHD